ent-Aprepitant |
|
| Synonyms: ent-Aprepitant; 5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; [2S-[2a(R*),3a]]-5-[[2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; USP Aprepitant Related Compound B; EP Aprepitant Impurity D | |
| Cat. No.: A66202 | CAS No.: 172822-29-6 |
| MDL.: | Formula: C23H21F7N4O3 |
| F.W.534.43 | Purity: 99％ |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 25mg | $9850.00 | Enter qty and click checkbox |
 
|
$9850.00 |
| Catalog Number： | A66202 | CAS No.: | 172822-29-6 | |
| MDL: | Formula: | C23H21F7N4O3 | ||
| F.W.: | 534.43 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | No Data Available | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Chawla, S., et al.: Cancer, 97, 2290 (2003), Huskey, S., et al.: Drug Metab. Dispos., 31, 785 (2003), Warr, D., et al.: Eur. J. Cancer, 41, 1278 (2005), | |||
| Application: | The (S,R,S)-enantiomer of Aprepitant, an unwanted enantiomer of Aprepitant in bulk drug and formulation samples of Aprepitant. | |||
| Category: | Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, | |||